4,900 Galicians Participate in Combined Flu and Covid-19 Vaccine Trial
Nearly 5,000 patients have participated in a clinical trial across Galicia testing a combined vaccine for influenza and COVID-19, according to data released by the regional health department.
- A total of 4,900 people participated in the Combogal clinical trial during its first two weekend rollouts across 14 hospitals managed by the Galician Health Service.
- The trial specifically evaluates whether administering a single combined inoculation yields higher efficacy than receiving separate influenza and COVID-19 injections simultaneously.
- Outreach for the study reached approximately 730,000 residents aged 65 and older via SMS text messages linked to routine vaccination campaign appointments.
Combogal Trial Enrolls 4,900 People Across 14 Hospitals
The clinical evaluation, titled the Combogal trial, operates across all 14 hospitals within the Servizo Galego de Saúde network. During the first two weekends of the five consecutive weekend study window, 4,900 individuals enrolled across the regional health system. At the Hospital Comarcal do Salnés, 186 patients participated in the testing protocol.
The administrative framework ties directly into the broader regional vaccination schedule. When public health officials issue SMS notifications and appointment calls to adults aged 65 and older—a demographic totaling roughly 730,000 citizens across Galicia—recipients receive information regarding the option to travel to a designated hospital site to join the trial.
Study Tests Combined Dose Against Standard Separate Injections
The study aims to determine if a single combined dose offers superior protection compared to the standard of care, which involves two separate injections administered simultaneously. Investigators track multiple clinical endpoints, including hospitalization rates, complications, and mortality risks tied to either pathogen.
Following initial testing and regulatory clearance, this phase evaluates the combined formulation within the general population. The study protocol continues across the remaining three weekends at all participating healthcare facilities.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.